COSMOS Pharmaceutical (TSE:3349) EBIT : 円34,553 Mil (TTM As of Feb. 2024)

COSMOS Pharmaceutical EBIT Chart

COSMOS Pharmaceutical Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
EBIT		Get a 7-Day Free Trial					27,216.00	30,471.00	38,656.00	33,100.00	32,824.00

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBIT	Get a 7-Day Free Trial															7,479.00	8,558.00	9,654.00	7,594.00	8,747.00

Competitive Comparison of COSMOS Pharmaceutical's EBIT

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

COSMOS Pharmaceutical's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's EV-to-EBIT falls into.

COSMOS Pharmaceutical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円34,553 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical  (TSE:3349) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

COSMOS Pharmaceutical's annualized ROC % for the quarter that ended in Feb. 2024 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

COSMOS Pharmaceutical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

COSMOS Pharmaceutical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical EBIT Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (TSE:3349) Business Description